Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors

Oral Oncology

Volumn 49, Issue 5, 2013, Pages 401-406

  Lim, Chwee Ming ^a,c   Clump, David A ^a   Heron, Dwight E ^a,b   Ferris, Robert L ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Head and neck tumors; Stereotactic radiation therapy

Indexed keywords

CETUXIMAB; FLUORODEOXYGLUCOSE F 18;

CANCER RECURRENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK TUMOR; HUMAN; PRIORITY JOURNAL; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PATIENT COMPLIANCE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SAFETY; SALVAGE THERAPY;

EID: 84875711467     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.12.009     Document Type: Review

References (37)

1. Y.C. Ahn, K.C. Lee, D.Y. Kim, S.J. Huh, I.H. Yeo, and D.H. Lim Fractionated stereotactic radiation therapy for extracranial head and neck tumors Int J Radiat Oncol Biol Phys 48 2 2000 501 505
2. J. Xiao, G. Xu, and Y. Miao Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 51 1 2001 164 170 (Pubitemid 32758876)
3. D.E. Heron, R.L. Ferris, M. Karamouzis, R.S. Andrade, E.L. Deeb, and S. Burton Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial Int J Radiat Oncol Biol Phys 75 5 2009 1493 1500
4. G. Voynov, D.E. Heron, S. Burton, J. Grandis, A. Quinn, and R. Ferris Frameless stereotactic radiosurgery for recurrent head and neck carcinoma Technol Cancer Res Treat 5 5 2006 529 535 (Pubitemid 44606275)
5. D.T. Chua, J.S. Sham, K.N. Hung, L.H. Leung, P.W. Cheng, and P.W. Kwong Salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery Head Neck 23 9 2001 791 798 (Pubitemid 32754870)
6. A.J. Cmelak, R.S. Cox, J.R. Adler, W.E. Fee Jr., and D.R. Goffinet Radiosurgery for skull base malignancies and nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 37 5 1997 997 1003 (Pubitemid 27230022)
7. P.C. Pai, C.C. Chuang, K.C. Wei, N.M. Tsang, C.K. Tseng, and C.N. Chang Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma Head Neck 24 8 2002 748 753
8. A. Mintz, and D.E. Heron CyberKnife(R) robotic stereotactic radiosurgery and stereotactic body radiation therapy Technol Cancer Res Treat 9 6 2010 539 540
9. J.C. Rwigema, D.E. Heron, R.L. Ferris, M. Gibson, A. Quinn, and Y. Yang Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience Am J Clin Oncol 33 3 2010 286 293
10. J.C. Rwigema, D.E. Heron, R.L. Ferris, R.S. Andrade, M.K. Gibson, and Y. Yang The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy Am J Clin Oncol 34 4 2011 372 379
11. S.D. Chang, W. Main, D.P. Martin, I.C. Gibbs, and M.P. Heilbrun An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system Neurosurgery 52 1 2003 140 146 discussion 6-7
12. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 1 2007 43 66 (Pubitemid 46148091)
13. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and neck cancer N Engl J Med 345 26 2001 1890 1900 (Pubitemid 33716564)
14. A.J. Munro An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer Br J Cancer 71 1 1995 83 91
15. R.C. DeConti, and D. Schoenfeld A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer Cancer 48 5 1981 1061 1072 (Pubitemid 11052878)
16. J. Fontanesi, D. Hetzler, and J. Ross Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192 Int J Radiat Oncol Biol Phys 17 2 1989 365 369 (Pubitemid 19203085)
17. W.K. Hong, R.H. Bromer, D.A. Amato, S. Shapshay, M. Vincent, and C. Vaughan Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy Cancer 56 6 1985 1242 1245 (Pubitemid 15230562)
18. J. Pomp, P.C. Levendag, and W.L. van Putten Reirradiation of recurrent tumors in the head and neck Am J Clin Oncol 11 5 1988 543 549
19. K.R. Stevens Jr., A. Britsch, and W.T. Moss High-dose reirradiation of head and neck cancer with curative intent Int J Radiat Oncol Biol Phys 29 4 1994 687 698 (Pubitemid 24241307)
20. Vargo JHD, Ferris RL, Rwigema JC, Wegner RE, Kalash R, Ohr J, et al., Burton S prospective evaluation of patient-reported quality-of-life outcomes following stereotactic body radiotherapy ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer. American College of Radiation Oncology. Ft Meyers, FL; 2012.
21. M. Cengiz, G. Ozyigit, G. Yazici, A. Dogan, F. Yildiz, and F. Zorlu Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors Int J Radiat Oncol Biol Phys 81 1 2011 104 109
22. B. Comet, A. Kramar, M. Faivre-Pierret, S. Dewas, B. Coche-Dequeant, and M. Degardin Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study Int J Radiat Oncol Biol Phys 2012
23. J.A. Vargo, R.E. Wegner, D.E. Heron, R.L. Ferris, J.C. Rwigema, and A. Quinn Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck Head Neck 2011
24. R. De Crevoisier, J. Bourhis, C. Domenge, P. Wibault, S. Koscielny, and A. Lusinchi Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 11 1998 3556 3562 (Pubitemid 28506768)
25. F. Siddiqui, M. Patel, M. Khan, S. McLean, J. Dragovic, and J.Y. Jin Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region Int J Radiat Oncol Biol Phys 74 4 2009 1047 1053
26. K.R. Unger, C.E. Lominska, J.F. Deeken, B.J. Davidson, K.A. Newkirk, and G.J. Gagnon Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 77 5 2010 1411 1419
27. K.W. Roh, J.S. Jang, M.S. Kim, D.I. Sun, B.S. Kim, and S.L. Jung Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer Int J Radiat Oncol Biol Phys 74 5 2009 1348 1355
28. A.J. Paravati, D.E. Heron, P.A. Gardner, C. Snyderman, C. Ozhasoglu, and A. Quinn Combined endoscopic endonasal surgery and fractionated stereotactic radiosurgery (fSRS) for complex cranial base tumors-early clinical outcomes Technol Cancer Res Treat 9 5 2010 489 498
29. P.P. Phillips, and K.D. Olsen Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature Ann Otol Rhinol Laryngol 104 2 1995 100 104
30. E. Tsukamoto, and S. Ochi PET/CT today: system and its impact on cancer diagnosis Ann Nucl Med 20 4 2006 255 267 (Pubitemid 44033266)
31. D.E. Heron, R.S. Andrade, S. Beriwal, and R.P. Smith PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response Am J Clin Oncol 31 4 2008 352 362
32. M.S. Rajagopalan, and D.E. Heron Role of PET/CT imaging in stereotactic body radiotherapy Future Oncol 6 2 2010 305 317
33. A.P. Jeavons, and P.E.T. Small-animal Cameras J Nucl Med 41 8 2000 1442 1443
34. K. Wang, D.E. Heron, J.C. Flickinger, J.C. Rwigema, R.L. Ferris, and G.J. Kubicek A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer Head Neck Oncol 4 2012 12
35. J.A. Bonner, P.M. Harari, J. Giralt, N. Azarnia, D.M. Shin, and R.B. Cohen Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 6 2006 567 578 (Pubitemid 43209104)
36. J.A. Bonner, P.M. Harari, J. Giralt, R.B. Cohen, C.U. Jones, and R.K. Sur Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 1 2010 21 28
37. D.E. Heron, J.C. Rwigema, M.K. Gibson, S.A. Burton, A.E. Quinn, and R.L. Ferris Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study Am J Clin Oncol 34 2 2011 165 172